These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2230905)

  • 21. [Susceptibility testing of clinical strains of Legionella spp. isolated in Japan].
    Murakami H; Matsumoto T; Kobayashi T; Isogai K; Kashitani F; Furuya N; Tateda K; Yamaguchi K
    Kansenshogaku Zasshi; 2001 Jan; 75(1):1-6. PubMed ID: 11218381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
    Edlund C; Nord CE
    Infection; 1988; 16(1):8-12. PubMed ID: 3283041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones.
    Dudley MN
    Am J Med; 1991 Dec; 91(6A):45S-50S. PubMed ID: 1767806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone.
    Oh H; Nord CE; Barkholt L; Hedberg M; Edlund C
    Infection; 2000 Sep; 28(5):272-7. PubMed ID: 11073132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Lactobacillus acidophilus on the normal intestinal microflora after administration of two antimicrobial agents.
    Lidbeck A; Edlund C; Gustafsson JA; Kager L; Nord CE
    Infection; 1988; 16(6):329-36. PubMed ID: 3146551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin.
    Nyberg SD; Osterblad M; Hakanen AJ; Löfmark S; Edlund C; Huovinen P; Jalava J
    Scand J Infect Dis; 2007; 39(6-7):514-20. PubMed ID: 17577812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections.
    Edlund C; Nord CE
    J Antimicrob Chemother; 2000 Aug; 46 Suppl A():41-48. PubMed ID: 10969051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of antimicrobial agents on human intestinal flora, with particular reference to Bacteroides species.
    Mette U; Werner H; Krasemann C; Ungerechts J
    Infection; 1980; 8 Suppl 2():S215-8. PubMed ID: 7053193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survey of Bacteroides fragilis susceptibility patterns in France.
    Breuil J; Burnat C; Patey O; Dublanchet A
    J Antimicrob Chemother; 1989 Jul; 24(1):69-75. PubMed ID: 2777729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenteral administration of antimicrobial drugs can affect the intestinal microflora of rat.
    Benini A; Bertazzoni Minelli E
    Pharmacol Res; 1992; 25 Suppl 1():75-6. PubMed ID: 1387213
    [No Abstract]   [Full Text] [Related]  

  • 31. Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora.
    Nord CE; Gajjar DA; Grasela DM
    Clin Microbiol Infect; 2002 Apr; 8(4):229-39. PubMed ID: 12047415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of new quinolones on the human gastrointestinal microflora.
    Nord CE
    Rev Infect Dis; 1988; 10 Suppl 1():S193-6. PubMed ID: 3279492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance: a class effect?
    Prieto J; Calvo A; Gómez-Lus ML
    J Antimicrob Chemother; 2002 Dec; 50 Suppl S2():7-12. PubMed ID: 12556428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in-vitro antibiotic susceptibility of Chlamydia pneumoniae.
    Fenelon LE; Mumtaz G; Ridgway GL
    J Antimicrob Chemother; 1990 Dec; 26(6):763-7. PubMed ID: 2081718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotic sensitivity of forty-four strains of group EF4 bacteria: study of minimum inhibitory concentrations using the agar dilution method].
    Lion C; de Monchy P; Weber M; Conroy MC; Mory F; Burdin JC
    Pathol Biol (Paris); 1992 May; 40(5):471-8. PubMed ID: 1495829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    J Antimicrob Chemother; 2002 Sep; 50(3):411-20. PubMed ID: 12205068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of Chlamydia pecorum to macrolides, tetracyclines, quinolones and beta-lactam.
    Pudjiatmoko ; Fukushi H; Ochiai Y; Yamaguchi T; Hirai K
    Microbiol Immunol; 1998; 42(1):61-3. PubMed ID: 9525782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial agents acting against anaerobes.
    Hamilton-Miller JM
    J Antimicrob Chemother; 1975 Sep; 1(3):273-89. PubMed ID: 171248
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrobial treatment of periodontal diseases disturbs the human ecology: a review.
    Edlund C; Hedberg M; Nord CE
    J Chemother; 1996 Oct; 8(5):331-41. PubMed ID: 8957712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin.
    Epstein ME; Amodio-Groton M; Sadick NS
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):365-81; quiz 382-4. PubMed ID: 9308549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.